Method and system for treating congestive heart failure

• US 9,872,987 B2
• Filed: 04/22/2013
• Issued: 01/23/2018
• Est. Priority Date: 06/08/2004
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Libbus, Imad, Ni, Quan, Lee, Kent
• Primary Examiner(s): Carey, Michael
• Assistant Examiner(s): Patel, Natasha
• Application Number:
  US13/867,778
• Publication Number:
  US 20130238052A1
• Time in Patent Office: 1,737 Days
• Field of Search: 607 6, 607 7, 607 9, 607 17, 607 62, 600508, 600509
• CPC Class Codes: A61N 1/3601 of respiratory organs
• CPC Class Codes: A61N 1/3611 Respiration control stimulating respiratory organs A61N1/3601
• CPC Class Codes: A61N 1/3614 based on impedance measurement

Abstract

An approach to treating congestive heart failure includes monitoring pulmonary congestion. Monitoring pulmonary congestion includes sensing a physiologic parameter using a sensor implanted within the patient. The method further comprises delivering a congestive heart failure therapy using a stimulator implanted within the patient. Delivering the congestive heart failure therapy includes delivering electrical stimulation to the patient using the sensed parameter to control the congestive heart failure therapy.

Claims

1. A method for using an implantable system implanted within a congestive heart failure patient, comprising:

monitoring pulmonary congestion, wherein monitoring pulmonary congestion includes sensing a physiologic parameter using a sensor implanted within the patient, wherein sensing the physiologic parameter includes sensing ventricular filling pressure; and

delivering a congestive heart failure therapy using a stimulator implanted within the patient, wherein delivering the congestive heart failure therapy includes delivering electrical stimulation to the patient using the sensed parameter to control the congestive heart failure therapy, the congestive heart failure therapy including a neural stimulation therapy.

2. The method of claim 1, wherein delivering the congestive heart failure therapy includes delivering a baroreflex therapy.

3. The method of claim 1, wherein delivering the congestive heart failure therapy further includes delivering myocardial stimulation.

4. The method of claim 1, wherein delivering the congestive heart failure therapy includes delivering at least one disordered breathing therapy.

5. The method of claim 4, wherein delivering at least one disordered breathing therapy includes stimulating a hypoglossal nerve.

6. The method of claim 4, wherein delivering at least one disordered breathing therapy includes stimulating a phrenic nerve.

7. The method of claim 1, wherein delivering the congestive heart failure therapy includes delivering at least two disordered breathing therapies, wherein delivering the at least two disordered breathing therapies includes:

stimulating at least two of a baroreflex target to cause a baroreflex response in the patient, a phrenic nerve, or a hypoglossal nerve; and

coordinating the delivery of the disordered breathing therapies.

8. The method of claim 1, wherein the delivering electrical stimulation to the patient using the sensed parameter to control the congestive heart failure therapy includes delivering the electrical stimulating using a closed loop control system and using the sensed parameter for feedback to the closed loop control system.

9. The method of claim 1, wherein sensing a physiologic parameter includes using sensing impedance.

10. An implantable system for implantation within a congestive heart failure patient, comprising:

an implantable sensor configured to sense a physiologic parameter;

a stimulator configured to deliver a congestive heart failure therapy, the congestive heart failure therapy including a neurostimulation therapy, wherein in delivering the congestive heart failure therapy the stimulator is configured to deliver electrical stimulation to the patient; and

a controller configured to monitor pulmonary congestion using the sensed physiologic parameter and use the sensed physiologic parameter to control the congestive heart failure therapy, wherein the congestive heart failure therapy includes at least two disordered breathing therapies, the at least two disordered breathing therapies including at least two of;

a baroreflex target to cause a baroreflex response in the patient, a phrenic nerve, or a hypoglossal nerve; and

the controller is configured to coordinate the delivery of the disordered breathing therapies.

11. The system of claim 10, wherein the congestive heart failure therapy includes a baroreflex therapy.

12. The system of claim 10, wherein the congestive heart failure therapy further includes myocardial stimulation.

13. The system of claim 10, wherein the congestive heart failure therapy includes at least one disordered breathing therapy.

14. The system of claim 13, wherein the at least one disordered breathing therapy includes electrical stimulation of a hypoglossal nerve.

15. The system of claim 13, wherein the at least one disordered breathing therapy includes electrical stimulation of a phrenic nerve.

16. The system of claim 10, wherein the controller is configured to deliver the electrical stimulating using a closed loop control system and use the sensed parameter for feedback to the closed loop control system.

17. The system of claim 10, wherein the sensor is configured to sense impedance.

18. An implantable system for implantation within a congestive heart failure patient, comprising:

an implantable sensor configured to sense a physiologic parameter, wherein the sensor is configured to sense ventricular filling pressure;

a stimulator configured to deliver a congestive heart failure therapy, wherein in delivering the congestive heart failure therapy the stimulator is configured to deliver electrical stimulation to the patient; and

a controller configured to monitor pulmonary congestion using the sensed physiologic parameter and use the sensed physiologic parameter to control the congestive heart failure therapy.

19. The system of claim 18, wherein the stimulator configured to deliver the congestive heart failure therapy is configured to stimulate a phrenic nerve to deliver at least one disordered breathing therapy.

20. The system of claim 18, wherein delivering the congestive heart failure therapy further includes delivering myocardial stimulation.